Pfizer, FDA, CDC Hid Proven Harms to Male Sperm Quality, Testes Function, from mRNA Vaccine Ingredients
"This review of documents and studies, culminating with one that shows shocking data about mRNA vaccines conclusively reducing men’s fertility, gives rise to important questions..."
This is an excellent article by Amy Kelly, part of the daily clout team (Naomi Wolf dailyclout.io )
We included her article with her receipts/studies, and added some direct links here as well.
Pfizer, FDA, CDC Hid Proven Harms to Male Sperm Quality, Testes Function, from mRNA Vaccine Ingredients
213, 246, 398, 431, 575, 607, 751, 783, 918, 948, 1073, 1103, 1226, 1255, 1378, 1406, 1522, 1549, 1663, 1688, 1813, 1836, 1949, 1969, 2081, 2100, 2211, 2228, and 2337.
Summary of the Public Assessment Report for COVID-19 Vaccine Pfizer/BioNTech (updated august 2022)
No genotoxicity studies are planned for BNT162b2
Carcinogenicity studies with BNT162b2 have not been conducted
A combined fertility and developmental study (including teratogenicity and postnatal investigations) in rats is ongoing.
Prenatal and postnatal development, including maternal function
No such studies have been done.
Studies in which the offspring (juvenile animals) are dosed and/or further evaluated
No such studies have been done.
Toxicity conclusions
The absence of reproductive toxicity data is a reflection of the speed of development to first identify and select COVID-19 mRNA Vaccine BNT162b2 for clinical testing and its rapid development to meet the ongoing urgent health need. In principle, a decision on licensing a vaccine could be taken in these circumstances without data from reproductive toxicity studies animals, but there are studies ongoing and these will be provided when available. In the context of supply under Regulation 174, it is considered that sufficient reassurance of safe use of the vaccine in pregnant women cannot be provided at the present time: however, use in women of childbearing potential could be supported provided healthcare professionals are advised to rule out known or suspected pregnancy prior to vaccination. Women who are breastfeeding should also not be vaccinated. These judgements reflect the absence of data at the present time and do not reflect a specific finding of concern. Adequate advice with regard to women of childbearing potential, pregnant women and breastfeeding women has been provided in both the Information for UK Healthcare Professionals and the Information for UK recipients.
Enlargement of spleen and increased spleen weights correlated microscopically to increased haematopoiesis and increased haematopoiesis was also evident in the bone marrow. These findings are likely secondary to the immune/inflammatory responses to the vaccine.
How does OSHA’s Hazard Communication Standard (HCS 2012) define reproductive toxicity
https://www.schc.org/assets/docs/ghs_info_sheets/schc_osha_reproductive_toxicity_4-4-16.pdf
A Tissue Distribution Study of a [3H]-Labelled Lipid Nanoparticle-mRNA Formulation Containing ALC-0315 and ALC-0159 Following Intramuscular Administration in Wistar Han Rats
mRNA vaccine ingredients travel throughout the body and gather in organs, including in the testes. P 24
https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_185350.pdf
mRNA vaccines resulting in “anti-sperm antibodies” – that is to say, antibodies that treat sperm as an “invader”, and damage or kill it – is a known adverse event related to this form of vaccination p 30
5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021
https://www.phmpt.org/wp-content/uploads/2022/04/reissue_5.3.6-postmarketing-experience.pdf
https://www.invitra.com/en/antisperm-antibodies/
mRNA vaccines cause a staggering drop in semen concentration and total motile count. [Gat, Itai, et al. “Covid-19 Vaccination BNT162B2 Temporarily Impairs Semen Concentration and Total Motile Count among Semen Donors.” Wiley Online Library, Andrology, 17 June 2022, https://onlinelibrary.wiley.com/doi/10.1111/andr.13209.
COVID-19 vaccination does not reduce chances of conception, study suggests
But when Pfizer eventually did look at the mRNA vaccine’s impact on male fertility, the company used “untreated male” rats for its “Reproductive and Developmental Toxicity” studies. The untreated males mated with female rats that had been dosed with BNT162b2, Pfizer’s mRNA vaccine. [2.4 Nonclinical Overview,
https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M2_24_nonclinical-overview.pdf, p. 29.]
However, the FDA received the Pfizer document,” A Tissue Distribution Study of a [3H]-Labelled Lipid Nanoparticle-mRNA Formulation Containing ALC-0315 and ALC-0159 Following Intramuscular Administration in Wistar Han Rats,” on November 9, 2020, over a month before Pfizer’s vaccine received Emergency Use Authorization (EUA) and began to be injected into humans worldwide. The document shows shocking biodistribution results. [“A Tissue Distribution Study of a [3H]-Labelled Lipid Nanoparticle-mRNA Formulation Containing ALC-0315 and ALC-0159 Following Intramuscular Administration in Wistar Han Rats,” https://www.phmpt.org/wp-content/uploads/2022/03/125742_S1_M4_4223_185350.pdf, p. 24.]